Figma sheds $11 billion in market value days after blockbuster IPO
San Francisco, California-based Figma shares had scored a massive 250% gain during their market debut on Thursday when they were priced at $33 but finished at $115.50, giving the company a market capitalization of about $56.3 billion.
Figma's market value closed at $59.5 billion on Friday after its shares rose 5.6% to $122. The shares traded as low as $92.75 on Monday, down 23%, reducing its market value to about $45.2 billion.
"The excitement for Figma's business is not over, but the euphoria that's gone into its heady stock pricing seems to be deflating as those that wanted an early piece of the action bought in during market hours while some IPO recipients are probably taking sweet profits," said Michael Ashley Schulman, chief investment officer at Running Point Capital in Los Angeles.
Founded in 2012 and led by CEO Dylan Field, Figma provides cloud-based collaborative design tools, with a roster of marquee clients including Alphabet (GOOGL.O), opens new tab, Microsoft (MSFT.O), opens new tab, Netflix (NFLX.O), opens new tab and Uber (UBER.N), opens new tab.
Field owns about 54.2 million Figma shares worth about $5 billion after selling 2.35 million shares in the IPO. As is common in many Silicon Valley startups, Field retains 74.1% voting power over Figma given his holdings of Class B shares.
Adobe (ADBE.O), opens new tab had abandoned a $20 billion deal to acquire Figma in 2023 following antitrust pushback from regulators in Europe and the UK.
"With Figma at a $46 billion market capitalization, Adobe's failed buyout offer must now seem like a distant memory," Schulman added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
30 minutes ago
- Reuters
Hims and Hers misses revenue estimates on decreasing wholesale demand
NEW YORK, Aug 4 (Reuters) - Hims and Hers Health (HIMS.N), opens new tab missed Wall Street estimates for second-quarter revenue on Monday, hit by weakness in its wholesale business, sending its shares down 9% in extended trading. The results follow the U.S. Food and Drug Administration's sunset deadline for telehealth companies to end mass compounding. Hims and rival telehealth companies have launched programs that offer "personalized" versions of semaglutide, the active ingredient in weight-loss drug Wegovy, at doses not accessible through the branded manufacturers. Wegovy maker Novo Nordisk (NVOH.P), opens new tab has characterized mass personalization as illegal, and analysts have questioned whether Hims will be able to sustain its growth following the crackdown. Hims and Hers reported quarterly revenue of $544.8 million, missing analysts' average expectation of $551.6 million. The company's wholesale unit, which represents non-prescription product sales to retailers through wholesale purchasing agreements, posted quarterly sales of $7.95 million, down 10% from a year ago. On a year-over-year basis, subscribers increased 31% to 2.44 million in the second quarter. Subscribers rose 38% in the first three months of the year. The company reported a quarterly profit of 17 cents per share, higher than the average analyst estimate of 15 cents, according to LSEG data.
Reuters
an hour ago
- Reuters
Hims and Hers beats quarterly profit on steady subscription growth
NEW YORK, Aug 4 (Reuters) - Hims and Hers Health (HIMS.N), opens new tab beat Wall Street estimates for second-quarter profit on Monday, aided by continued subscription growth and surging volume in the telehealth company's weight-loss business. The company reported a quarterly profit of 17 cents per share, higher than the average analyst estimate of 15 cents, according to LSEG data. However, shares fell about 10% in extended trading as quarterly revenue of $544.8 million missed analysts' average expectation of $551.6 million.
Reuters
an hour ago
- Reuters
Exclusive: Fed's Daly says time is nearing for rate cuts, may need more than two
Aug 4 (Reuters) - San Francisco Federal Reserve Bank President Mary Daly on Monday said that given mounting evidence that the U.S. job market is softening and no signs of persistent tariff-driven inflation, the time is nearing for interest rate cuts. "I was willing to wait another cycle, but I can't wait forever," Daly said of the Fed's decision last week to leave short-term borrowing costs in their 4.25%-4.50% range rather than cut them, as a couple of her colleagues wanted and as President Donald Trump has demanded. While that doesn't mean a September rate cut is a lock, she said, "I would lean to thinking that every meeting going forward is a live meeting to think about these policy adjustments." The two quarter-point interest-rate cuts that Fed policymakers back in June penciled in for this year still "look to be an appropriate amount of recalibration, and less important is, does it happen in September and December than does it happen at all kinds of permutations to get those two cuts." Daly said there is still plenty of data including a couple of labor market and inflation reports due out before the Fed's policy-setting meeting, in September, and she's keeping an open mind. "We of course could do fewer than two (rate cuts) if inflation picks up and spills over or if the labor market springs back," Daly said. But "I think the more likely thing is that we might have to do more than also should be prepared in my judgment to do more if the labor market looks to be entering that period of weakness and we still haven't seen spillovers to inflation." A Labor Department report Friday showed U.S. employers added just 73,000 jobs last month, and massive revisions to previously reported data showed only 33,000 jobs were added in the two prior months. Those figures, to Daly's mind, don't mean the job market is precariously weak - in times of economic flux, she said, raw employment numbers are often less informative than ratios like the unemployment rate, which ticked up just a tenth of a percentage point in July to 4.2%. Still, she said, looking at a broad dashboard of labor-market measures, there is "evidence after piece of evidence" that the labor market is softening quite a bit compared to last year. "I would see further softening as an unwelcome result," she said. "I'm comfortable with the decision we made in July, but I am increasingly less comfortable with making that decision again and again." At the same time, she said, there's no evidence that tariff-driven price increases are seeping more broadly into inflation, and if the Fed waits long enough to be certain it won't -- a process that could take six months or a year, she said - the Fed will "for sure" be too late to move. The Fed is approaching a "tradeoff space where you are trying to make a judgment about where does policy need to be to continue to put downward pressure on inflation, and where does it need to be to continue to make sure that sustainable employment can be achieved," she said. "That's why I didn't think that July was a necessary change, but I do think, increasingly, policy is not aligned."
